DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
Hopper MA, Dropik AR, Walker JS, Novak JP, Laverty MS, Manske MK, Wu X, Wenzl K, Krull JE, Sarangi V, Maurer MJ, Yang ZZ, Del Busso MD, Habermann TM, Link BK, Rimsza LM, Witzig TE, Ansell SM, Cerhan JR, Jevremovic D, Novak AJ.
Hopper MA, et al. Among authors: del busso md.
Blood Cancer J. 2024 Oct 9;14(1):172. doi: 10.1038/s41408-024-01145-0.
Blood Cancer J. 2024.
PMID: 39384745
Free PMC article.